‍‍

Oslo, Norway, 12 February 2026, RESPINOR AS, a Norwegian medical technology company advancing diaphragm monitoring in critical care, today announced that it has signed a distributor agreement with Eden Medical (UK) Ltd, securing exclusive distribution of RESPINOR DXT in England, Scotland and Wales. The agreement includes initial purchase commitments, marking the first commercial sales of RESPINOR DXT in the Great Britain region.

RESPINOR DXT is a non-invasive, ultrasound-based medical device designed to monitor diaphragm movement continuously and in real time. By providing objective, actionable data, the device supports clinicians during ventilator weaning and helps identify patients at increased risk of extubation failure, a key challenge in intensive care units worldwide.

“We are excited to partner with Eden Medical, a well-established leader in distributing high-quality medical technologies across UK”, said Trude Tingvoll, CEO, RESPINOR AS. “Their deep expertise and strong relationships with ICU clinicians make them an ideal partner as we take this important next step in our commercialization journey. This agreement validates the growing need for improved respiratory monitoring and brings RESPINOR DXT closer to the patients who need it most.”

The agreement expands RESPINOR’s commercial presence in Europe and represents a pivotal milestone ahead of further international rollouts.

About RESPINOR
RESPINOR AS is a Norwegian medical technology company dedicated to transforming diaphragm monitoring in intensive care. Its first product, RESPINOR DXT, is CE-marked and clinically validated to support diaphragm monitoring in mechanically ventilated patients. RESPINOR partners with leading clinical institutions to bring innovative, evidence-based tools to the bedside.

Abour Eden Medical
Eden Medical (UK) Ltd is an award-winning company selling, distributing and servicing medical products and equipment to hospitals and homecare communities across the UK.

Eden Medical (UK) Ltd offers a broad range of products, specialising in neonatal, respiratory and obstetric care products. We aim to support our customers, and improve the lives of those in their care, through incredible sales support and innovative, high-quality products.

Contact:
Trude Tingvoll
CEO, RESPINOR AS
t.tingvoll@respinor.com
+47 474 53 314

‍